——————————
参考文献:
1、von Minckwitz G, et al.,Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.N Engl J Med. 2017 Jul 13;377(2):122-131.
2、Ciara C. O'Sullivan, MD,et al., Pertuzumab and Its Accelerated Approval: Evolving Treatment Paradigms and New Challenges in the Management of HER2-Positive Breast Cancer, Oncology Journal, Mar 15, 2014
3、Swain SM, et al., Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. N Engl J Med. 2015 Feb 19;372(8):724-34.